CKD Bio

063160 · KOSPI · ₩063160 · 종근당바이오

₩12,350▼ ₩30 (0.24%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me

Filings

  • Major management matter relevant to investors투자판단관련주요경영사항Aug 14, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
  • Preliminary earnings영업(잠정)실적(공정공시)Jul 31, 2026Open on DART
  • Disclosure Related to Sustainability Management Report, etc. (Voluntary Disclosure)지속가능경영보고서등관련사항(자율공시)Jun 26, 2026Open on DART
  • Disclosure of Corporate Governance Report기업지배구조보고서공시Jun 1, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
  • Preliminary earnings영업(잠정)실적(공정공시)Apr 24, 2026Open on DART
  • Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 26, 2026Open on DART
  • Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
  • Audit report submitted감사보고서제출Mar 16, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의Feb 25, 2026Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Feb 25, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Feb 25, 2026Open on DART
  • Change in revenue or profit of 30% or more매출액또는손익구조30%(대규모법인은15%)이상변경Jan 30, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항Jan 19, 2026Open on DART
  • Shareholder Register Closure for Cash/Stock Dividend (Record Date) Decision현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정Dec 11, 2025Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 11, 2025Open on DART
  • Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
  • Preliminary earnings영업(잠정)실적(공정공시)Oct 31, 2025Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항Sep 17, 2025Open on DART
  • Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
  • Preliminary earnings영업(잠정)실적(공정공시)Jul 25, 2025Open on DART
  • Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
  • Preliminary earnings영업(잠정)실적(공정공시)Apr 25, 2025Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항 (티엠버스주200단위(클로스트리디움보툴리눔독소A형)제조판매 품목허가 신청)Apr 9, 2025Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항 (티엠버스주100단위(클로스트리디움보툴리눔독소A형) 제조판매 품목허가 승인)Apr 1, 2025Open on DART
  • Annual general meeting results정기주주총회결과Mar 26, 2025Open on DART
  • Audit report submitted감사보고서제출Mar 18, 2025Open on DART
  • Annual report (Dec 2024)사업보고서 (2024.12)Mar 18, 2025Open on DART
  • Cash dividend decision현금ㆍ현물배당결정Feb 25, 2025Open on DART
  • Shareholders' meeting called주주총회소집결의Feb 25, 2025Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Feb 25, 2025Open on DART
  • Notice of shareholders' meeting주주총회소집공고Feb 25, 2025Open on DART
  • Change in revenue or profit of 30% or more매출액또는손익구조30%(대규모법인은15%)이상변경Jan 24, 2025Open on DART
  • Shareholder Register Closure for Cash/Stock Dividend (Record Date) Decision현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정Dec 13, 2024Open on DART
  • Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 13, 2024Open on DART
  • Quarterly report (Sep 2024)분기보고서 (2024.09)Nov 14, 2024Open on DART
  • Preliminary earnings영업(잠정)실적(공정공시)Oct 25, 2024Open on DART
  • Half-year report (Jun 2024)반기보고서 (2024.06)Aug 14, 2024Open on DART
  • Preliminary earnings영업(잠정)실적(공정공시)Jul 26, 2024Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항May 24, 2024Open on DART
  • Quarterly report (Mar 2024)분기보고서 (2024.03)May 16, 2024Open on DART
  • Preliminary earnings영업(잠정)실적(공정공시)Apr 26, 2024Open on DART
  • Change of Representative Director (Representative Executive Officer) (Informational Disclosure)대표이사(대표집행임원)변경(안내공시)Mar 28, 2024Open on DART
  • Annual general meeting results정기주주총회결과Mar 28, 2024Open on DART
  • Audit report submitted감사보고서제출Mar 20, 2024Open on DART
  • Annual report (Dec 2023)사업보고서 (2023.12)Mar 20, 2024Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항Mar 6, 2024Open on DART
  • Shareholders' meeting called주주총회소집결의Feb 28, 2024Open on DART

Titles in Korean until English translations are added.

Also known as: CKD Bio / 종근당바이오 / 063160 / KRX:063160

Source: KRX statistical information